Abnormally expressed long non-coding RNAs in prognosis of Osteosarcoma: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Abnormally expressed long non-coding RNAs in prognosis of Osteosarcoma: A systematic review and meta-analysis

Published:2018-11 Issue: Volume:13 Page:76-90
ISSN:2212-1374
Container-title:Journal of Bone Oncology
language:en
Short-container-title:Journal of Bone Oncology

Author:

Chen Delong,Wang Haibin,Zhang Meng,Jiang Shan,Zhou Chi,Fang Bin,Chen Peng^ORCID

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Oncology

Reference52 articles.

1. MicroRNAs and potential targets in osteosarcoma: review;Sampson;Front. Pediatr.,2015

2. Using epidemiology and genomics to understand osteosarcoma etiology;Savage;Sarcoma,2011

3. Osteosarcoma: current treatment and a collaborative pathway to success;Isakoff;J. Clin. Oncol.,2015

4. A systematic review of p53 as a biomarker of survival in patients with osteosarcoma;Fu;Tumour Biol.,2013

5. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the surveillance, epidemiology, and end results program;Mirabello;Cancer-Am Cancer Soc.,2009

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential Expression of Non-Coding RNAs in Stem Cell Development and Therapeutics of Bone Disorders;Cells;2023-04-14

2. LPI-MAM: Predicting lncRNA-Protein Interactions with miRNAs as Mediators Based on Deep Learning;Hans Journal of Computational Biology;2023

3. Clinicopathologic significance and prognostic value of circRNAs in osteosarcoma: a systematic review and meta-analysis;Journal of Orthopaedic Surgery and Research;2021-10-07

4. The value of lncRNAs as prognostic biomarkers on clinical outcomes in osteosarcoma: a meta-analysis;BMC Cancer;2021-02-27

5. Principal Component Regression Analysis for lncRNA-Disease Association Prediction Based on Pathological Stage Data;IEEE Access;2021